Dr. Francesca Palandri is a medical doctor at the University of Bologna in Italy
July 24, 2025
Video
Ojjaara helps patients with myelofibrosis by reducing spleen size, easing symptoms, and improving anemia to boost independence from blood transfusions.
July 18, 2025
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
Inlexzo Offers New Option for Patients With Unresponsive Bladder Cancer
Managing Lynch Syndrome
New Directions in Treatment for Patients With GIST
More Patients Are Living Beyond Liver Cancer Thanks to Expanding Care